Ruth E. Stevens - 23 May 2024 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Director
Signature
By: /s/ Ruth E. Stevens
Issuer symbol
VINC
Transactions as of
23 May 2024
Net transactions value
$0
Form type
4
Filing time
28 May 2024, 16:36:35 UTC
Previous filing
30 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VINC Stock Option (right to buy) Award $0 +15,000 $0.000000 15,000 23 May 2024 Common Stock 15,000 $0.7036 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of May 23, 2025, the next annual meeting of stockholders, or the consummation of a change of control, subject to the director's continued service.